Overview
Treatment of sexually transmitted diseases refers to the clinical management of infections acquired through sexual contact, with the dual goals of curing or controlling disease in the individual and interrupting transmission within the community. Therapy is determined by the causative agent. Bacterial infections such as syphilis, gonorrhea, and chlamydia are managed with targeted antimicrobial regimens guided by susceptibility patterns and standardized treatment guidelines. Viral infections, including HIV and herpes, are not curable but are controlled with long-term antiviral therapy that suppresses replication, reduces symptoms, and lowers infectiousness, while HPV-associated lesions and warts may require ablative or surgical removal. Effective treatment depends on accurate diagnosis, appropriate drug selection and dosing, completion of the full regimen, and management of co-infections, which frequently occur together. Partner notification and concurrent treatment are integral to preventing reinfection and limiting spread, and follow-up testing confirms cure or monitors disease control. The emergence of antimicrobial resistance, particularly in gonorrhea, complicates therapy and underscores the importance of surveillance, stewardship, and evolving treatment protocols. Access to timely care, adherence support, and integration with screening and prevention services strongly influence outcomes. Treatment thus operates at the intersection of individual clinical care and population-level control, requiring evidence-based regimens, monitoring of resistance, and coordinated management of sexual partners.
Research published in this journal
6 peer-reviewed articles, ranked by relevance. Each links to its DOI.